Training Study to Characterise Biomarkers to the Engerix B Vaccine

This study has been completed.
Sponsor:
Collaborators:
Innovative Medicines Initiative
GlaxoSmithKline
Information provided by (Responsible Party):
University of Surrey
ClinicalTrials.gov Identifier:
NCT01771354
First received: November 15, 2012
Last updated: August 8, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)